《血液学杂志》.2005年.第12期
......
- A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocyti
- HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
- CLL, but not normal, B cells are dependent on autocrine VeGF and 41 integrin for chemokine-induced motility on and through endothelium
- Intronic splicing of hyaluronan synthase 1(HAS1): a biologically relevant indicator of poor outcome in multiple myeloma
- Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone(FND) pl
- Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leuk
- Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion pro
- Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice
- Platelet activation in cystic fibrosis
- Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackf
- An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone:
- A classification system for cross-reactive material-negative factor XI deficiency
- High level of endothelial cell-specific gene expression by a combination of the 5' flanking region and the 5' half of the first intron of th
- Angiopoietin-1 promotes LYVe-1-positive lymphatic vessel formation
- Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
- Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1 in the circulation
- Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis
- Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII
- Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo
- The hydration state of human red blood cells and their susceptibility to invasion by Plasmodium falciparum
- Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA ge
- emergent autoimmunity in graft-versus-host disease
- Copper-dependent activation of hypoxia-inducible factor(HIF)-1: implications for ceruloplasmin regulation
- Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
- Phenotypic characterization of the human myeloma cell growth fraction
- Lnk inhibits erythropoiesis and epo-dependent JAK2 activation and downstream signaling pathways
- Src homology 2 domain-containing inositol-5-phosphatase 1(SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosph
- expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors
- Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
- Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4(CD244)
- Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses
- Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
- Gaucher disease and cancer incidence: a study from the Gaucher Registry
- Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential
- Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
- Fusion of eML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)
- Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immun
- Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tosi
- CD25+CD4+ regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in
- Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic develo
- The homeobox gene HeX regulates proliferation and differentiation of hemangioblasts and endothelial cells during eS cell differentiation
- Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
- Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive
- Farnesyltransferase inhibitor R115777(Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhib
- Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
- Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lympho
- Cyclooxygenase-2(COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome
- Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells